Loading...

TNGX TANGO THERAPEUTICS INC Management Changes 8-K Filing

TNG

TNGX

TANGO THERAPEUTICS INC

(TNGX)

2026 8-K

Board Resignations

Management Change

Leadership Changes

Earnings Report

Leadership Changes

Director Appointment

Stock Sales Update

Financial Results Update

Stock Offering Announcement

Financial Update

Management Change

Financial Statements

Increase in authorized shares

Financial Statements

New Partnership

Funding Increase

Clinical Trial Update

Filing with Quantitative Data

Financial Update

Filing with Quantitative Data

Private Placement

Quantitative Data

Filing with Quantitative Data

External Links:

On January 7, 2026, Tango Therapeutics announced that Barbara Weber resigned as CEO effective January 8, 2026, and Malte Peters has been appointed as the new CEO on the same date. As of December 31, 2025, the company reported $343 million in cash and securities.

AI Assistant

TANGO THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.